ATCOR by CardieXATCOR by CardieXAtcor_Logo_30hATCOR by CardieX
  • Solutions
    • Healthcare
    • Clinical Trials & RWE
    • Academia / Research
  • Therapeutic Areas
    • Overview
    • Hypertension
    • Renal Disease
    • Heart Failure
    • Cognitive Impairment
    • Diabetes
    • COPD
  • Technology
    • SphygmoCor PWA
    • SphygmoCor PWV
    • Oscar 2 With SphygmoCor® Inside
    • Arty Heart Health – TicWatch GTH Pro
  • Resources
    • Blog
    • Publications
    • Case Studies
    • White Papers
    • Videos
  • Customers
    • Register
    • Customer Log-in
    • Technical Support
  • About
    • Overview
    • Partnerships
    • Intellectual Property
    • News & Media
    • ASX Announcements
Contact
✕

COVID-19 and Heart Damage: Latest Studies

August 31, 2020

As researchers, clinicians, and the general public struggle to understand the nature and direction of COVID-19, new clues and insights are emerging all the time. Case in point: two new studies from Germany and appearing in JAMA Cardiology point to permanent heart damage in COVID-19 patients, even among individuals who were healthy before they recovered from their initial symptoms.

Although COVID-19 clearly attacks the respiratory tract, its cardiac involvement appears to be significant as well. The two new studies follow numerous others that have explored the cardiac health/COVID-19 connection.

Study 1

In the first of the new reports, the authors evaluated cardiac magnetic resonance (CMR) images from 100 COVID-19 patients ages 45 to 53 and compared them with CMR images of similar individuals (controls: 50 healthy and 57 risk-factor matched) who did not have the disease. One third of the patients had been hospitalized for COVID while the remaining patients recovered at home. (1)

Slightly more than three-quarters (78 patients) who recovered from COVID-19 showed structural changes to their hearts, even two months after recovery. All but two of them demonstrated biomarkers usually seen in individuals who have had a heart attack, and 60 had myocarditis.

More specifically, compared with controls, patients who recovered from COVID-19 had:

  • Lower left ventricular ejection fraction
  • Higher left ventricle volumes
  • Greater left ventricle mass
  • Raised myocardial native T1 and T2

According to the study’s co-author, Dr. Valentina Puntmann, a cardiologist, clinical pharmacologist, and consultant physician at University Hospital Frankfurt, Germany, she, her fellow researchers, and the patients “were both surprised by the intensity and prevalence of these findings.” (2)

Study 2

This study involved reviewing the autopsy reports from 39 COVID-19 patients ages 78 to 89. Overall, the SARS-CoV-2 virus was documented in 24 (61.5%) of the patients, while the viral load was greater than 1000 copies per microgram in 16 (41.0%). (3)

Study co-author and cardiologist Dirk Westermann of the University Heart and Vascular Centre in Hamburg noted that “We see signs of viral replication in those that are heavily infected. At this point in time, however, he explained that “we don’t know the long-term consequences of the changes in gene expression,” emphasizing that “it’s obviously not good to have that increased level of inflammation.”(2)

Bottom line

Cardiac involvement in COVID-19 patients, including those who are relatively healthy prior to infection, is an emerging concern and highlights the need for clinicians to evaluate the cardiovascular risk factors of all their patients. Use of state-of-the-art diagnostic techniques that gather information on central arterial blood pressure, arterial inflammation, arterial stiffness, and pulse wave reflections, among others, will be critical as we tackle the COVID-19 pandemic and is consequences.

References

  1. Puntmann VO et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiology2020 Jul 27
  2. Mazziotta J. Three-quarters of recovered coronavirus patients have heart damage months later, study finds. People.com 2020 Jul 28
  3. Lindner D et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiology 2020 Jul 27

Share

Related posts

blueberries can improve heart health

Blueberries contain a high concentration of anthocyanins, powerful polyphenols that improve vascular functioning.

April 14, 2023

Can a Daily Cup of Blueberries Improve Arterial Stiffness?


Read more
Elderly couple kissing
April 5, 2023

Patients with Parkinson’s Disease May Have Lower Risk of Heart Attack 


Read more
April 5, 2023

Diversity in FDA Clinical Trials Gets a Boost From New Legislation 


Read more

ATCOR by CardieX

Solutions

  • Healthcare
  • Clinical Trials & RWE
  • Academia / Research

Theraputic Areas

  • Overview

Technology

  • SphygmoCor PWA
  • SphygmoCor PWV
  • Oscar 2 with SphygmoCor Inside

Resources

  • Blog
  • Publications
  • Case Studies
  • White Papers
  • Videos

About

  • Overview
  • Partnerships
  • Intellectual Property
  • News & Media
  • ASX Announcements
  • Privacy Policy
  • Disclaimer
  • Acceptable Use Policy

Contact

  • Technical Support
  • Contact Us
  • +1 (630) 228-8871
  • Email Us
  • Email Support

The CARDIEX group of companies is pleased to be a member of these esteemed professional organizations.
Copyright © 2024 ATCOR. All Rights Reserved.

Software Downloads – Quick Descriptions

XCEL Installation Package V1.3

XCEL V1.3 is the latest ATCOR release of the base XCEL software.  It is a required installation for all clinical practice, academic research, and clinical trials.


XCEL Secure Data Option Installation Package 

XCEL Secure Data Option software enables Part11 readiness for clinical practice, academic research, and clinical trials.  Prior to install, confirm that the XCEL V1.3 software is fully installed prior to the XCEL Secure Installation Package. Contact Us for more information.


Calibration Kit Software

For customers who have the XCEL calibration kit, this software is used for the annual calibration of the SphygmoCor XCEL.  The SphygmoCor XCEL Calibration Kit, sold separately, is required for this calibration procedure.